Skip to main content
Premium Trial:

Request an Annual Quote

QL2 Joins Microsoft’s BioIT Alliance

NEW YORK (GenomeWeb News) — Data extraction and integration company QL2 Software said it has joined BioIT Alliance, a Microsoft-born multi-industry research organization.
 
With solutions focused on business intelligence, enterprise search and text analysis, QL2 joins a crew of big-name players, including Applied Biosystems, Affymetrix, Hewlett-Packard, and the Scripps Research Institute, which are among the group’s founding members.
 
The BioIT Alliance’s goal is to develop and improve biomedical information technologies on the Microsoft platform.
 
QL2 said it will collaborate with other members to share information such as case studies and whitepapers, contribute expertise in data integration and help other software partners provide biomarker discovery solutions.
 
QL2 also said that the BioIT Alliance has developed a “second proof of concept,” which the company says will “accelerate the discovery and validation of biomarkers.”

Filed under

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.